Edition:
United States

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

1.87USD
18 May 2018
Change (% chg)

$0.10 (+5.65%)
Prev Close
$1.77
Open
$1.80
Day's High
$1.87
Day's Low
$1.78
Volume
58,783
Avg. Vol
190,751
52-wk High
$9.55
52-wk Low
$1.51

Latest Key Developments (Source: Significant Developments)

Advaxis Announces Executive Leadership Changes
Monday, 23 Apr 2018 08:00am EDT 

April 23 (Reuters) - Advaxis Inc ::ADVAXIS ANNOUNCES EXECUTIVE LEADERSHIP CHANGES.ADVAXIS INC - KENNETH BERLIN HAS BEEN APPOINTED AS PRESIDENT AND CHIEF EXECUTIVE OFFICER.ADVAXIS INC - INTERIM CEO ANTHONY LOMBARDO WILL REMAIN WITH ADVAXIS FOR A PERIOD OF TIME.  Full Article

Aratana Therapeutics Granted Conditional License For A Canine Osteosarcoma Therapeutic
Wednesday, 20 Dec 2017 08:05am EST 

Dec 20 (Reuters) - Advaxis Inc ::ARATANA THERAPEUTICS GRANTED CONDITIONAL LICENSE FOR A CANINE OSTEOSARCOMA THERAPEUTIC.ARATANA THERAPEUTICS-U.S. DEPARTMENT OF AGRICULTURE CENTER FOR VETERINARY BIOLOGICS GRANTED CONDITIONAL LICENSE​ FOR CANINE OSTEOSARCOMA VACCINE,AT-014.  Full Article

Amgen reports 8.9 pct passive stake in Advaxis as of Aug 1
Tuesday, 2 Aug 2016 09:06am EDT 

Amgen Inc Reports 8.9 Pct Passive Stake In Advaxis Inc As Of August 1 :Sec filing.  Full Article

Advaxis files for common stock offering
Tuesday, 2 Aug 2016 08:49am EDT 

Advaxis Inc :Files for common stock offering of up to 3.05 million shares - SEC filing.  Full Article

BRIEF-Advaxis Announces Executive Leadership Changes

* ADVAXIS INC - KENNETH BERLIN HAS BEEN APPOINTED AS PRESIDENT AND CHIEF EXECUTIVE OFFICER